Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside

World Journal of Hepatology

Volumn 7, Issue 9, 2015, Pages 1209-1232

  Hu, Bing ^a   Wang, Shuang Shuang ^a   Du, Qin ^a  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chinese herb; Chinese herbal formula; Hepatocarcinoma; Prevention; Therapeutic principle; Traditional Chinese medicine; Traditional Chinese medicine syndrome (Zheng); Treatment

Indexed keywords

EID: 84929738067     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i9.1209     Document Type: Review

References (205)

1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255 [PMID: 22353262 DOI: 10.1016/S0140-6736(11)61347-0]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
3. Chen JG, Chen WQ, Zhang SW, Zheng RS, Zhu J, Zhang YH.[Incidence and mortality of liver cancer in China: an analysis on data from the National Registration System between 2003 and 2007]. Zhonghua Liuxingbingxue ZaZhi 2012; 33: 547-553 [PMID: 22883257]
4. Fan JH, Wang JB, Jiang Y, Xiang W, Liang H, Wei WQ, Qiao YL, Boffetta P. Attributable causes of liver cancer mortality and incidence in china. Asian Pac J Cancer Prev 2013; 14: 7251-7256 [PMID: 24460283 DOI: 10.7314/APJCP.2013.14.12.7251]
5. de Kretser TA, Lee GT, Thorne HJ, Jose DG. Monoclonal antibody CI-panHu defines a pan-human cell-surface antigen unique to higher primates. Immunology 1986; 57: 579-585 [PMID: 2420708 DOI: 10.1016/j.jnci.2013.08.002]
6. Tang ZY. Combination of traditional Chinese medicine and western medicine in the treatment of liver cancer. Linchuang Gandanbing Zazhi 2011; 27: 449-450
7. Wu MC. [Traditional Chinese medicine in prevention and treatment of liver cancer: function, status and existed problems]. Zhongxiyi Jiehe Xuebao 2003; 1: 163-164 [PMID: 15339547 DOI: 10.3736/jcim20030302]
8. Li M, Qiao C, Qin L, Zhang J, Ling C. Application of traditional Chinese medicine injection in treatment of primary liver cancer: a review. J Tradit Chin Med 2012; 32: 299-307 [PMID: 23297547 DOI: 10.1016/S0254-6272(13)60029-1]
9. Wu P, Dugoua JJ, Eyawo O, Mills EJ. Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. J Exp Clin Cancer Res 2009; 28: 112 [PMID: 19674474 DOI: 10.1186/1756-9966-28-112]
10. Hu B, Du Q, Shen KP, Xu L. Principles and scientific basis of Traditional Chinese Medicine in cancer treatment. J Bioanal Biomed 2012; S6: 005 [DOI: 10.4172/1948-593X.S6-005]
11. Du Q, Hu B, Shen KP, An HM. Progress in TCM pathogenesis and treatment of liver cancer. Shijie Zhongxiyi Jiehe Zazhi 2010; 5: 814-817
12. Hu B, An HM, Shen KP. Syndrome differential anti-cancer and scientific anti-cancer. Zhongguo Minzu Minjian Yiyao 2009; 18: 33-34
13. Wang Y, Ji G, Wang YQ, Zhang W, Xing LJ, Dong GH, Wang YN, Lin SH. Effects of traditional Chinese medicine on TGF-ßIIR expression in DMN induced hepatic precancerous lesion in rats. Zhejiang Zhongxiyi Jiehe Zazhi 2001; 11: 23-24
14. Tatsuta M, Iishi H, Baba M, Nakaizumi A, Uehara H. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats. Jpn J Cancer Res 1991; 82: 987-992 [PMID: 1682293 DOI: 10.1111/j.1349-7006.1991.tb01932.x]
15. Tatsuta M, Iishi H, Baba M, Nakaizumi A, Uehara H. Inhibition by shi-quan-da-bu-tang (TJ-48) of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats. Eur J Cancer 1994; 30A: 74-78 [PMID: 8142169 DOI: 10.1016/S0959-8049(05)80022-X]
16. Zou KC, Song WM, Xu FX, Lin SM, Guo GY, Wang HW, Liu L, Zhou JP, Zhang HF, Sun YQ. Effect of Nourishing-Yin Decoction and Removing-Toxic-Heat Decoction on histological observation in rats Liver during canceration. Zhongguo Zhongxiyi Jiehe Zazhi 1995; 15: 238-240, 396
17. Guan Y, Zhou Z, Zhang C, Ruan Y, Wu Z. Effect of A-L tonic capsule on DNA content in rat experimental hepatocarcinogenesis. J Huazhong Univ Sci Technolog Med Sci 2002; 22: 12-13, 16 [PMID: 12658771 DOI: 10.1007/BF02904776]
18. Zou J, Chen JJ. Preventive effect of prescription of Nourishing Shen on rat hepatocarcinoma induced by Diethylnitrosamine. Zhongxiyi Jiehe Ganbing Zazhi 2003; 13: 278-280
19. Liu C, Liu P, Wang XS, Xu LM, Hu YY. Experimental study of Fu-zheng-hua-yu formula for liver cancer prevention. Zhongguo Zhongxiyi Jiehe Piwei Zazhi 1995; 33: 163-166
20. Li X, Shi ZM, Feng P, Wen ZY, Wang XJ. Effect of Qi-protecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis. World J Gastroenterol 2007; 13: 4192-4198 [PMID: 17696247]
21. Wen Z, Shi Z, Feng P, Xue X, Dong K, Wang X. Modulation of energy metabolic enzyme expression in N-nitrosodiethylaminemediated hepatocarcinogenesis by Chinese herbs, Huqi San. Biofactors 2008; 34: 303-312 [PMID: 19850985 DOI: 10.3233/BIO-2009-1084]
22. Qian Y, Ling CQ. Preventive effect of Ganfujian granule on experimental hepatocarcinoma in rats. World J Gastroenterol 2004; 10: 755-757 [PMID: 14991955]
23. Qiu JX. [The effect of "SRRS" recipe on the formation of liver cancer in the rat]. Zhongxiyi Jiehe Zazhi 1988; 8: 734-735, 710 [PMID: 3248335]
24. Zhang B, Li Q, Yin PH, Zhao CG, Li XQ, Gao H, Sun J, Fan ZZ. Involvement of miR-199a downregulation in the preventive effects of Jianpi Jiedu Recipe against experimental hepatocarcinoma in rats. Shijie Huaren Xiaohua Zazhi 2010; 18: 125-131
25. Zhang B, Li Q, Yin PH, Zhao CG, Gao H, Sun J, Fan ZZ. Study on AKT/PI3K signaling pathway and prevenion effect of Jianpi Jiedu Recipe in rats with experimental hepatocarcinogenesis. Zhongguo Zhongxiyi Jiehe Xiaohua Zazhi 2010; 18: 4-9
26. Gao HS, Yao SK, Yin F. The effect of Ganzheng solution on the ICAM-1 expression in liver tissues of rat in the diethylnitrosamine induced hepatocarcinogenesis. Hebei Zhongyi 2007; 29: 848-850
27. Nie G, Long AH, Fu QL, Li HM, Ming AP, Xiao L, Yan XS, Wang BX. Zao-Lian mixture prevents Diethylnitrosamine induced hepatocirrhosis and hepatocaecinogenesis in rats. Zhongxiyi Jiehe Ganbing Zazhi 1998; 8: 107-109
28. Lee CY, Hsu YC, Wang JY, Chen CC, Chiu JH. Chemopreventive effect of selenium and Chinese medicinal herbs on N-nitrosobis(2-oxopropyl)amine-induced hepatocellular carcinoma in Syrian hamsters. Liver Int 2008; 28: 841-855 [PMID: 18346132 DOI: 10.1111/j.1478-3231.2008.01698.x]
29. Fang ZQ, Guan DY, Liang SH, Qin HY, Li HY. Comparative study on functions of different therapies on liver cancer in mice. Shanghai Zhongyiyao Daxue Xuebao 2002; 16: 42-46
30. Guan DY, Lu HX, Fang ZQ. Study on the regulation of different therapies on some signal moleculars transcriptions in the pathway of Ras/MAPK. Zhongguo Zhongyi Jichu Yixue Zazhi 2002; 8: 36-38
31. Guan D, Fang Z, Lu H, Li H. Preliminary investigation on regulating effects of different TCM treatments on transcription of the correlated genes of liver cancer in rats. J Tradit Chin Med 2003; 23: 62-66 [PMID: 12747207]
32. Cui R, Wang B, Zhang F, Chen G, Yin S. Suppressive effect of herbal compound 861 on chemical hepatocarcinogenesis in rats. Chin Med J (Engl) 2003; 116: 378-382 [PMID: 12781041]
33. Zhu MJ, Zhang H, Gao SS, Zhang XS. Effects of new anti-tumor formula on protecting against synergistic hepatocarcinogenesis of hepatitis B virus expression and aflatoxin B1 and free radicals metabolism in HBV large envelope transgenic mice. Liaoning Zhongyi Xueyuan Xuebao 2003; 5: 263-264
34. Li X, Wu XG. [Effects of ginseng on hepatocellular carcinoma in rats induced by diethylnitrosamine--a further study]. J Tongji Med Univ 1991; 11: 73-80 [PMID: 1816418]
35. Yan RQ, Chen ZY, Qin GZ, Qin LL. Effects of twelve herbs on Aflatoxin B1 induced hepatocarcinogensis in rats. Guangxi Yixueyuan Xuebao 1986; 3: 21-23
36. Ruan CC, Liang Y, Liu ZH. Inhibition of 12 Chinese Traditional Medicinal herbs on mutagenic effects induced by Aflatoxin B1. Ai Zheng 1987; 8: 29-31
37. Shen M, Yin Z. [Effect of Boschniakia rossica extract on antioxidative activities in rat hepatic preneoplasia induced by diethylnitrosamine]. Zhongguo Zhongyao Zazhi 1999; 24: 746-78, 765 [PMID: 12205985]
38. Yin ZZ, Jin HL, Li TZ, Lee JJ, Kim YH, Lee CH, Lee KH, Hyun BH. [Inhibitory effect of methanol extract of Boschniakia rossica Fedtsch. et Flerov on rat hepatic preneoplastic lesions induced by diethylnitrosamine]. Zhongguo Zhongyao Zazhi 1998; 23: 424-426, 448- inside back cover [PMID: 11601354]
39. Dai ZJ, Wang XJ, Ji ZZ, Liu XX, Kang HF, Diao Y, Ma XB, Liu L, Ren HT. [Inhibitory effects of Scutellaria barbate extracts on diethylnitrosamine-induced hepatocarcinoma in rats]. Zhong Yao Cai 2009; 32: 568-571 [PMID: 19645244]
40. Lin YL, Hsu JD, Chou FP, Lee MJ, Shiow SJ, Wang CJ. Suppressive effect of penta-acetyl geniposide on the development of gamma-glutamyl transpeptidase foci-induced by aflatoxin B(1) in rats. Chem Biol Interact 2000; 128: 115-126 [PMID: 11024451 DOI: 10.1016/S0009-2797(00)00193-9]
41. Zhao X, Zhang JJ, Wang X, Bu XY, Lou YQ, Zhang GL. Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats. Biomed Pharmacother 2008; 62: 567-572 [PMID: 17418998 DOI: 10.1016/j.biopha.2007.02.009]
42. Luo RX, Lin RT, Lu YB, Cai L, Yi YN. Inhibition of Artemisa capillaris Thunb on mutagenic effects induced by Aflatoxin B1. Fujian Yixueyuan Xuebao 1990; 24: 352-354
43. Liu J, Yang CF, Wasser S, Shen HM, Tan CE, Ong CN. Protection of salvia miltiorrhiza against aflatoxin-B1-induced hepatocarcinogenesis in Fischer 344 rats dual mechanisms involved. Life Sci 2001; 69: 309-326 [PMID: 11441922 DOI: 10.1016/S0024-3205(01)01116-X]
44. Kim J, Ha HL, Moon HB, Lee YW, Cho CK, Yoo HS, Yu DY. Chemopreventive effect of Curcuma longa Linn on liver pathology in HBx transgenic mice. Integr Cancer Ther 2011; 10: 168-177 [PMID: 21190953 DOI: 10.1177/1534735410380613]
45. Deng W, Xiang Q, Li B. Effects of prescription of Sanqi on rats with hepatocarcinoma induced by diethylnireosamine. Guangxi Yixue 2013; 35: 1442-1446
46. Ohtaki Y, Nomura M, Hida T, Miyamoto K, Kanitani M, Aizawa T, Aburada M. Inhibition by gomisin A, a lignan compound, of hepatocarcinogenesis by 3'-methyl-4-dimethylaminoazobenzene in rats. Biol Pharm Bull 1994; 17: 808-814 [PMID: 7951143 DOI: 10.1248/bpb.17.808]
47. Zhang YH, WuJP. Effects of Jian-Pi-Huo-Xue Formula on in patients with hepatitis, hepatic cirrhosis and low level of AFP. Zhongxiyi Jiehe Ganbing Zazhi 2000; 10: 13-14
48. Zhang ZQ, Liu QF, Zhong SC, Huang TR, Wu YD, Wang TC, Huang NF, Liang RX. Epidemiological studies on Salvia miltiorrhiza for liver cancer prevention. Guangxi Yixue 1995; 17: 179-181
49. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, Monna T, Kobayashi K, Tango T. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995; 76: 743-749 [PMID: 8625175]
50. Zhao G, Lang QB, Ling CQ. Characteristics of 294 cases of primary liver cancer. Shijie Zhongxiyi Jiehe Zazhi 2008; 3: 275-277
51. Li YJ, Fang ZQ, Tang CL, Ma J, Guan DY, Chen DS. Clinical epidemiological investigation and research of syndrome distribution law in Chinese medicine of 2060 cases of primary liver carcinoma. Zhongguo Yiyao Xuebao 2003; 18: 144-146
52. Fang ZQ, Li YJ, Tang CL, Ma J, Guan DY, Chen DS. Analysis on characteristics of syndromes in 2060 cases of primary hepatic cancer. Zhongyi Zazhi 2004; 45: 53-54
53. Wang CJ, Hu Y, Fu TT, Huang XH, Dai XB, Shi L, Li YC, Xioang J. Syndrome distribution of primary liver cancer in Guangzhou area. Zhonghua Zhongyiyao Xuekan 2010; 28: 2314-2318
54. Yang XB, Long SQ, Wu WY, Deng H, Pan ZQ, He WF, Zhou YS, Liao GY, Ouyang YS, Li QP, Huang L, Hu XJ, Xiao SJ, Cai JZ.[The distribution of Chinese medicine syndrome types in primary liver cancer and their differences of the survival time: a clinical study]. Zhongguo Zhongxiyi Jiehe Zazhi 2013; 33: 911-914 [PMID: 24063211]
55. Wan X, Zhang YH. Relation betwwen syndrome and quality of life in patients with liver cancer. Guiyang Zhongyi Xueyuan Xuebao 2008; 30: 27-28
56. Zhang YH, Qin X, Xu J, Sun Z, Lang QB, Yue XQ, Zhai XF. A preliminary study on TCM compound syndrome characteristics of 58 patients with liver cancer before and after operation. Zhongxiyi Jiehe Ganbing Zazhi 2012; 22: 75-80
57. Ye Y, Qin LP, Yue XQ, Zhai XF, Xu J, Xiao KY, Huang F, Li B. Tongue changes in 103 perioperative patients with primary liver cancer. Zhongyi Zazhi 2014; 55: 48-52
58. Li YJ, Fang ZQ, Tang ZL, Ma J, Guan DY. Comparative study of TCM syndromes in liver cancer patients after TACE and surgery. Zhongyiyao Xuekan 2003; 21: 504-504
59. Yang SF, Lin YL. TCM Syndrome of Primary Liver Carcinoma before Interventional Treatment by Cluster Analysis. Zhongyiyao Xinxi Zazhi 2012; 19: 11-12
60. Zeng PH, Liu WS, Pan MQ, Xu K, Wu WY, Chang G, Jiang YL, Cai M. Study on development of syndrome in Chinese medicine during transcatheter arterial intervention in primary hepatic carcinoma. Hunan Zhongyiyao Daxue Xuebao 2008; 28: 54-56
61. Meng J, Qin LP, Liu L, Lang QB, Li B. Impact of TACE on Syndromes in PHC. Zhejiang Zhongyiyao Daxue Xuebao 2012; 36: 1194-1198
62. Zhang YH, Qin X, Xu J. [Analysis of Chinese medical syndrome features of patients with primary liver cancer before and after transcatheter arterial chemoembolization]. Zhongguo Zhongxiyi Jiehe Zazhi 2012; 32: 1171-1174 [PMID: 23185752]
63. He D. Study on change of TCM syndrome in patients with primary liver cancer before and after high intensity focus ultrasound treatment. Jianyan Yixue Yu Linchuang 2012; 9: 2676-2677
64. Chen QW, Huang XQ, Yang GJ, Dai WX, Lang QB, Yan SK, Zhou J, Zhang WD, Ling CQ. Preliminary study of serum metabonomics on Yang-deficiency Syndrome of patients with primary liver cancer. Zhonghua Zhongyiyao Xuekan 2012; 30: 526-529
65. Yang SF, Qiu SP, Liu QH. [Observation of serum protein fingerprinting in primary liver cancer patients of different Chinese medical syndromes before and after interventional treatment]. Zhongguo Zhongxiyi Jiehe Zazhi 2013; 33: 1352-1355 [PMID: 24432678]
66. Huang ZG, Zhang XQ, Ye YB, Chen HQ, Chen Q, Yang AL. Initial study on application of protein fingerprinting in Zheng differentiation-classification of primary liver cancer. Xiandai Zhongxiyi Jiehe Zazhi 2012; 21: 3660-3664
67. Weng L, Du J, He WT, Ling CQ. [Characteristic genomics of peripheral blood mononuclear cells of hepatocellular carcinoma patients with liver-kidney yin deficiency syndrome]. Zhongxiyi Jiehe Xuebao 2012; 10: 406-415 [PMID: 22500714 DOI: 10.3736/jcim20120409]
68. Su XK, Wu YS, Li YH, Yang XW, Lu YY, Chi JA. Relationship between TCM Syndrome Differentiation of liver cancer and adhesion degree of cancer Cell. Zhongguo Zhongxiyi Jiehe Waike Zazhi 2009; 15: 10-12
69. Su XK, Cheng YX, Lin SH. Correlation of Syndrome Differentiation of liver cancer with matrix degradation. Xin Zhongyi 2008; 40: 37-39
70. Pan ZQ, Fang ZQ, Lu WL. Comparative research on syndrome manifestation features in mice with H22 liver cancer and Lewis lung carcinoma. Beijing Zhongyiyao Daxue Xuebao 2008; 31: 184-188
71. Pan ZQ, Fang ZQ, Lu WL, Liang C, Wu ZH, Liu XM, Hou L, Zhang H, Zhuo SY, Liao MJ, Gao BF. [Differentially expressed genes in adrenal gland of H22 liver cancer mice with different syndromes and in different stages]. Zhongxiyi Jiehe Xuebao 2008; 6: 843-851 [PMID: 18664355 DOI: 10.3736/jcim20080814]
72. Chen Z, Chen HY, Lang QB, Li B, Zhai XF, Guo YY, Yue XQ, Ling CQ. Preventive effects of jiedu granules combined with cinobufacini injection versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: a case-control trial. Chin J Integr Med 2012; 18: 339-344 [PMID: 22549390]
73. Sun Z, Liang ST, Zhai XF, Lang QB, Zhou QH, Yue XQ, He J, Xu J, Zhu Y, Ling CQ. A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow-up. J Tradit Chin Med 2012; 32: 156-163 [PMID: 22876437 DOI: 10.1016/S0254-6272(13)60005-9]
74. Chen LW, Lin J, Chen W, Zhang W. [Effect of Chinese herbal medicine on patients with primary hepatic carcinoma in III stage during perioperational period: a report of 42 cases]. Zhongguo Zhongxiyi Jiehe Zazhi 2005; 25: 832-834 [PMID: 16250104]
75. Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study. Cancer 2009; 115: 5132-5138 [PMID: 19672999 DOI: 10.1002/cncr.24567]
76. Lin LZ, Zhou DH, Liu K, Wang FJ, Lan SQ, Ye XW. [Analysis on the prognostic factors in patients with large hepatocarcinoma treated by shentao ruangan pill and hydroxycamptothecine]. Zhongguo Zhongxiyi Jiehe Zazhi 2005; 25: 8-11 [PMID: 15719740]
77. Shao ZX, Cheng ZG, Yin X. [Clinical study on treatment of middle-advanced stage liver cancer by combined treatment of hepatic artery chemoembolization with gan'ai no. I and no. II]. Zhongguo Zhongxiyi Jiehe Zazhi 2001; 21: 168-170 [PMID: 12577328]
78. Wu GL, Zhang L, Li TY, Chen J, Yu GY, Li JP. Short-term effect of combined therapy with Jinlong Capsule and transcatheter arterial chemoembolization on patients with primary hepatic carcinoma and its influence on serum osteopontin expression. Chin J Integr Med 2010; 16: 109-113 [PMID: 20473734 DOI: 10.1007/s11655-010-0109-9]
79. Hou EC, Lu YX. [Primary hepatocarcinoma treated by traditional Chinese medicine combined with transcatheter arterial chemoembolization]. Zhongguo Zhongxiyi Jiehe Zazhi 2009; 29: 225-227 [PMID: 19548439]
80. Gao WB, Han JD, Du M. [Observation on efficiency of shelian capsule as adjuvant of embolismic chemotherapy on primary hepatic carcinoma]. Zhongguo Zhongxiyi Jiehe Zazhi 2005; 25: 980-982 [PMID: 16355611]
81. Lao Y. [Clinical study on effect of matrine injection to protect the liver function for patients with primary hepatic carcinoma after trans-artery chemo-embolization (TAE)]. Zhong Yao Cai 2005; 28: 637-638 [PMID: 16252735]
82. Zhang B, Huang G, Zhang Y, Chen X, Hu P, Xu B. [Clinical observation on prevention of "jia wei si jun zi tang" from damage of hepatic reserving function after intervention of liver cancer]. Zhong Yao Cai 2004; 27: 387-389 [PMID: 15376398]
83. Cheng JH, Chang G, Wu WY. [A controlled clinical study between hepatic arterial infusion with embolized curcuma aromatic oil and chemical drugs in treating primary liver cancer]. Zhongguo Zhongxiyi Jiehe Zazhi 2001; 21: 165-167 [PMID: 12577327]
84. Zheng C, Feng G, Liang H. Bletilla striata as a vascular embolizing agent in interventional treatment of primary hepatic carcinoma. Chin Med J (Engl) 1998; 111: 1060-1063 [PMID: 11263363]
85. Zheng C, Feng G, Zhou R. [New use of Bletilla striata as embolizing agent in the intervention treatment of hepatic carcinoma]. Zhonghua Zhongliu Zazhi 1996; 18: 305-307 [PMID: 9387329]
86. Lou HZ, Pan HM, Jin W. [Clinical study on treatment of primary liver cancer by Aidi injection combined with cool-tip radiofrequency ablation]. Zhongguo Zhongxiyi Jiehe Zazhi 2007; 27: 393-395 [PMID: 17650788]
87. Wang WR, Cui SD, Zeng LM. Clinical observation on treatment of mid-advanced patients with hepatocarcinoma by Xiao'aiping combined with ultrasound guided percutaneous radio-frequency. Zhongguo Zhongxiyi Jiehe Zazhi 2003; 2: 19-21
88. Zhang YW. Combinational treatment with ultrasound-guided percutaneous radiofrequency and Tianzhicao capsule in 90 cases patients with hepatocarcinoma. Dangdai Yixue 2010; 16: 6-8
89. Liu XT, Liu JB, Zhang ZQ, Liu SY. Jinlong capsule clinical observation of radiofrequency ablation technique for the treatment of primary liver cancer. Shoudu Yiyao 2013; (10): 47-48
90. Zhao HJ, Du J, Chen X. [Clinical study of Fuzheng Yiliu Recipe combined with microwave ablation on hepatocellular carcinoma]. Zhongguo Zhongxiyi Jiehe Zazhi 2012; 32: 32-34 [PMID: 22500387]
91. Lin JJ, Jin CN, Zheng ML, Ouyang XN, Zeng JX, Dai XH. Clinical study on treatment of primary hepatocellular carcinoma by Shenqi mixture combined with microwave coagulation. Chin J Integr Med 2005; 11: 104-110 [PMID: 16150196 DOI: 10.1007/BF02836465]
92. Guo ZJ, Lin JJ, Jin CY, Zhong YS. Clinical observation of combinational treatment with Aidi injection and microwave ablation in hepatocarcinoma patients. Zhongyiyao Tongbao 2006; 5: 51-54
93. Zhang SC, Li J, Yang LJ, Fan LH, Wang CX, Wang RC, He YS. Effect of Qiankun capsule combined with high-intensity focused ultrasound on the immunological function of patients with primary liver cancer. Zhongguo Zhongyi Jichu Yixue Zazhi 2005; 11: 367-380
94. Pan JY, Ma J, Jia L, Zhou YJ, Li YY. Effects of Fu-Zhen-Yang-Yin formula combination with high-intensity focused ultrasound in advanced liver cancer patients. Shijie Huaren Xiaohua Zazhi 2004; 12: 1750-1751
95. Wang XW, Chan RH. Effects of Syndrome differentiation based herbal therapy combination with sorafenib in patients with advanced hepatocarcinoma. Zhongguo Yiyao Daobao 2008; 5: 48-49
96. Feng LH, Chen YD, Zheng ZG, Gao YQ. Clinical observation of patients with primary liver cancer treated by sorafenib combined cinobufagin tablets. Zhongguo Aizheng Zazhi 2012; 22: 856-859
97. Tian HQ, Li HL, Wang B, Liang GW, Huang XQ, Huang ZQ, Lang JM, Zhang YP, Chen XZ, Chen YS. Treatment of middle/late stage primary hepatic carcinoma by Chinese medicine comprehensive therapy: A prospective randomized controlled study. Chin J Integr Med 2010; 16: 102-108 [PMID: 20473733 DOI: 10.1007/s11655-010-0102-3]
98. Xu K, Luo HY, Li LN. [Clinical study on comprehensive treatment of primary liver cancer mainly with chinese medicinal perfusion/embolization]. Zhongguo Zhongxiyi Jiehe Zazhi 2005; 25: 299-302 [PMID: 15892270]
99. Huang Z, Wang Y, Chen J, Wang R, Chen Q. Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients. J Tradit Chin Med 2013; 33: 34-38 [PMID: 23596809 DOI: 10.1016/S0254-6272(13)60097-7]
100. Chen Z, Zhai XF, Su YH, Wan XY, Li J, Xie JM, Gao B. [Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer]. Zhongxiyi Jiehe Xuebao 2003; 1: 184-186 [PMID: 15339556 DOI: 10.3736/jcim20030311]
101. Chu YP, Shen L, Bai Y. Efficacy observation of liver cancer at the later stage for the elderly treated with integration of Norcantharidin and Chinese medicine. Shijie Zhongxiyi Jiehe Xuebao 2012; 7: 765-767
102. Xu RQ, Huang ZF, Li HZ, Wei JS, Zhang ZJ, Xiang LY, Gui HT, Tan QQ. Effects of Jianpi Fuzheng decoction on symptom and immune function in patients with advanced liver cancer. Zhongxiyi Jiehe Ganbing Zazhi 2013; 23: 73-75
103. Chen QS, ChenY, Pei RQ, Huang WZ, Li CY, Zhou B, Chen YY. Clinical observation of 30 cases of late-stage primary hepatic cancer treated with Jianpi Yiliu Decoction. Shijie Zhongxiyi Jiehe Zazhi 2013; 8: 368-370
104. Yang YK, Qiu DZ, Wang GH, Gu XX, Fan Y, Tang CL. Clinical study on Jiawei Yiguanjian for improvement of the survival rate in advanced hepatocellular carcinoma patients. Zhongguo Linchuang Yixue 2011; 18: 818-820
105. Li X, Guan YS, Zhou XP, Sun L, Liu Y, He Q, Fu L, Mao YQ.[Anticarcinogenic effect of 20(R)-ginsenoside Rg3 on induced hepatocellular carcinoma in rats]. Sichuan Daxue Xuebao Yixueban 2005; 36: 217-220 [PMID: 15807271]
106. Chao JC, Chiang SW, Wang CC, Tsai YH, Wu MS. Hot waterextracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells. World J Gastroenterol 2006; 12: 4478-4484 [PMID: 16874858 DOI: 10.3748/wjg.v12.i28.4478]
107. Chen YL, Jian MH, Lin CC, Kang JC, Chen SP, Lin PC, Hung PJ, Chen JR, Chang WL, Lin SZ, Harn HJ. The induction of orphan nuclear receptor Nur77 expression by n-butylenephthalide as pharmaceuticals on hepatocellular carcinoma cell therapy. Mol Pharmacol 2008; 74: 1046-1058 [PMID: 18577687 DOI: 10.1124/mol.107.044800]
108. Li S, Dong P, Wang J, Zhang J, Gu J, Wu X, Wu W, Fei X, Zhang Z, Wang Y, Quan Z, Liu Y. Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Lett 2010; 298: 222-230 [PMID: 20674153 DOI: 10.1016/j.canlet.2010.07.009]
109. Hsu SH, Tsai TR, Lin CN, Yen MH, Kuo KW. Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis. Biochem Biophys Res Commun 1996; 229: 1-5 [PMID: 8954074 DOI: 10.1006/bbrc.1996.1748]
110. Zhang YN, Liu L, Ling CQ. [Inhibition effect of active fraction from Actinidia valvata on growth of transplanated mouse tumor cells and preliminary study of its mechanism]. Zhongguo Zhongyao Zazhi 2006; 31: 918-920 [PMID: 17048634]
111. Lin JM, Liu Y, Luo RC. [Inhibition activity of Scutellariae barbata extracts against human hepatocellular carcinoma cells]. Nanfang Yike Daxue Xuebao 2006; 26: 591-593 [PMID: 16762857]
112. Sa F, Gao JL, Fung KP, Zheng Y, Lee SM, Wang YT. Anti-proliferative and pro-apoptotic effect of Smilax glabra Roxb. extract on hepatoma cell lines. Chem Biol Interact 2008; 171: 1-14 [PMID: 17996228 DOI: 10.1016/j.cbi.2007.08.012]
113. Li Y, Li MY, Wang L, Jiang ZH, Li WY, Li H. [Induction of apoptosis of cultured hepatocarcinoma cell by essential oil of Artemisia Annul L]. Sichuan Daxue Xuebao Yixueban 2004; 35: 337-339 [PMID: 15181829]
114. Huang D, Zhang W, Huang D, Wu J. Antitumor activity of the aqueous extract from Sedum sarmentosum Bunge in vitro. Cancer Biother Radiopharm 2010; 25: 81-88 [PMID: 20187800 DOI: 10.1089/cbr.2009.0632]
115. Xie Q, Yang Y, Wang Z, Chen F, Zhang A, Liu C. Resveratrol-4-O-D-(2'-galloyl)-glucopyranoside isolated from Polygonum cuspidatum exhibits anti-hepatocellular carcinoma viability by inducing apoptosis via the JNK and ERK pathway. Molecules 2014; 19: 1592-1602 [PMID: 24473215 DOI: 10.3390/molecules19021592]
116. Hu YQ, Tan RX, Chu MY, Zhou J. Apoptosis in human hepatoma cell line SMMC-7721 induced by water-soluble macromolecular components of Artemisia capillaris Thunberg. Jpn J Cancer Res 2000; 91: 113-117 [PMID: 10744052 DOI: 10.1111/j.1349-7006.2000.tb00867.x]
117. Liu J, Shen HM, Ong CN. Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG(2) cells. Cancer Lett 2000; 153: 85-93 [PMID: 10779635]
118. Lee SM, Li ML, Tse YC, Leung SC, Lee MM, Tsui SK, Fung KP, Lee CY, Waye MM. Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci 2002; 71: 2267-2277 [PMID: 12215374 DOI: 10.1016/S0024-3205(02)01962-8]
119. Du Q, Hu B, An HM, Shen KP, Xu L, Deng S, Wei MM. Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol Rep 2013; 29: 1851-1858 [PMID: 23446753 DOI: 10.3892/or.2013.2310]
120. Chen F, Yang L, Wang XK, Zhang Y. Effects of the Alkaloids of Pinellia ternata on Proliferation of Human Hepatocarcinoma Cell Strain Bel-7402. Zhongguo Yaofang 2011; 43: 4048-4050
121. Yang ZH, Yin JY, Wei ZR, Yan WQ. Extract of Tian-Nan-Xing (Arisaema heterophyllum) induces apoptosis in human hepatocarcinoma SMMC-7721 cells and its mechanism. Zhongguo Laonianxue Zazhi 2007; 27: 142-144
122. Wang Y, Deng L, Zhong H, Wang Y, Jiang X, Chen J. Natural plant extract tubeimoside I promotes apoptosis-mediated cell death in cultured human hepatoma (HepG2) cells. Biol Pharm Bull 2011; 34: 831-838 [PMID: 21628880 DOI: 10.1248/bpb.34.831]
123. Kwon KB, Kim EK, Lim JG, Jeong ES, Shin BC, Jeon YS, Kim KS, Seo EA, Ryu DG. Molecular mechanisms of apoptosis induced by Scorpio water extract in human hepatoma HepG2 cells. World J Gastroenterol 2005; 11: 943-947 [PMID: 15742393 DOI: 10.3748/wjg.v11.i7.943]
124. Chang C, Zhu YQ, Mei JJ, Liu SQ, Luo J. Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells. J Exp Clin Cancer Res 2010; 29: 145 [PMID: 21059274 DOI: 10.1186/1756-9966-29-145]
125. Hu H, Chen D, Li Y, Zhang X. Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in-vitro and Balb/c nude mice invivo. J Pharm Pharmacol 2006; 58: 83-89 [PMID: 16393467 DOI: 10.1211/jpp.58.1.0010]
126. Song Q, Zhao JX, Zhu YZ. [Effect of fuzheng yiliu granule on H22 tumor cell apoptosis, p53 and caspase-3 gene expression in mice]. Zhongguo Zhongxiyi Jiehe Zazhi 2005; 25: 338-341 [PMID: 15892280]
127. Zhao JX, Guo FL, Bai DC, Wang XX. [Effects of fuzheng yiliu granules on apoptotic rate and mitochondrial membrane potential of hepatocellular carcinoma cell line H22 from mice]. Zhongxiyi Jiehe Xuebao 2006; 4: 271-274 [PMID: 16696914 DOI: 10.3736/jcim20060310]
128. Zhang YY, Liu FY, Zhang HL. Study on Apoptosis of hepatica carcinoma cell induced by Fuganchun 6 in Vitro. Hebei Beifang Xueyuan Xuebao Yixueban 2009; 26: 6-10
129. Zhong Y, Luo CL, An-Jun Z. [Effect of bushen jianpi decoction and its disassemble recipes on tumor growth in mice with transplanted primary hepatic carcinoma]. Zhongguo Zhongxiyi Jiehe Zazhi 2011; 31: 213-217 [PMID: 21425577]
130. Zhang X, Liu DQ, Liu YZ, Wang P, Chen XY. [Preliminary study on apoptosis of BEL-7402 cells induced by Chinese herbs for warming yang and dispersing stasis]. Zhongguo Zhongyao Zazhi 2000; 25: 428-430 [PMID: 12515227]
131. Jiang ZY, Hua HQ, Yang AZ, Qin SK. Effects of Fufangkushen Injection in combination with oxaliplatin and recombinant human endostatin injection on apoptosis in human hepatoma cell line SMMC-7721. Shijie Huaren Xiaohua Zazhi 2010; 18: 3396-3401
132. Huang XY, Wang L, Huang ZL, Zheng Q, Li QS, Tang ZY. Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential. J Cancer Res Clin Oncol 2009; 135: 1245-1255 [PMID: 19277711 DOI: 10.1007/s00432-009-0566-8]
133. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674 [PMID: 21376230 DOI: 10.1016/j. cell.2011.02.013]
134. Tsai YC, Wu WB, Chen BH. Preparation of carotenoids and chlorophylls from Gynostemma pentaphyllum (Thunb.) Makino and their antiproliferation effect on hepatoma cell. J Med Food 2010; 13: 1431-1442 [PMID: 20946022 DOI: 10.1089/jmf.2010.1165]
135. Tsai YC, Lin CL, Chen BH. Preparative chromatography of flavonoids and saponins in Gynostemma pentaphyllum and their antiproliferation effect on hepatoma cell. Phytomedicine 2010; 18: 2-10 [PMID: 21036575 DOI: 10.1016/j.phymed.2010.09.004]
136. Lin SB, Li CH, Lee SS, Kan LS. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 2003; 72: 2381-2390 [PMID: 12639703 DOI: 10.1016/S0024-3205(03)00124-3]
137. Lin JM, Liu Y, Luo RC. [Effect of Scutellaria barbata extract against human hepatocellular Hep-G2 cell proliferation and its mechanism]. Nanfang Yike Daxue Xuebao 2006; 26: 975-977 [PMID: 16864090]
138. Ye F, Che Y, McMillen E, Gorski J, Brodman D, Saw D, Jiang B, Zhang DY. The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells. Nutr Cancer 2009; 61: 530-537 [PMID: 19838925 DOI: 10.1080/01635580902803719]
139. Xie RF, Li ZC, Gao B, Shi ZN, Zhou X. Bufothionine, a possible effective component in cinobufocini injection for hepatocellular carcinoma. J Ethnopharmacol 2012; 141: 692-700 [PMID: 22210051 DOI: 10.1016/j.jep.2011.12.018]
140. Shi P, Huang Z, Chen G. Rhein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma BEL-7402 cells. Am J Chin Med 2008; 36: 805-813 [PMID: 18711776 DOI: 10.1142/S0192415X08006259]
141. Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT, Lin CC. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. J Gastroenterol Hepatol 2008; 23: e290-e299 [PMID: 18522681 DOI: 10.1111/j.1440-1746.2008.05390.x]
142. Kao ST, Yeh CC, Hsieh CC, Yang MD, Lee MR, Liu HS, Lin JG. The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sci 2001; 69: 1485-1496 [PMID: 11554610 DOI: 10.1016/S0024-3205(01)01226-7]
143. Cao Z, Lin W, Huang Z, Chen X, Zhao J, Zheng L, Ye H, Liu Z, Liao L, Du J. Ethyl acetate extraction from a Chinese herbal formula, Jiedu Xiaozheng Yin, inhibits the proliferation of hepatocellular carcinoma cells via induction of G0/G1 phase arrest in vivo and in vitro. Int J Oncol 2013; 42: 202-210 [PMID: 23165653 DOI: 10.3892/ijo.2012.1703]
144. Deng S, Hu B, An HM. Traditional Chinese Medicinal Syndromes and treatment in colorectal cancer. J Cancer Ther 2012; 3: 888-897 [DOI: 10.4236/jct.2012.326114]
145. Wang Z, Han W, Sui X, Fang Y, Pan H. Autophagy: A novel therapeutic target for hepatocarcinoma (Review). Oncol Lett 2014; 7: 1345-1351 [PMID: 24765136 DOI: 10.3892/ol.2014.1916]
146. Lin HM, Tseng HC, Wang CJ, Chyau CC, Liao KK, Peng PL, Chou FP. Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. J Agric Food Chem 2007; 55: 3620-3628 [PMID: 17419635 DOI: 10.1021/jf062406m]
147. Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis 2013; 34: 1331-1342 [PMID: 23393227 DOI: 10.1093/carcin/bgt060]
148. Miao Q, Bi LL, Li X, Miao S, Zhang J, Zhang S, Yang Q, Xie YH, Zhang J, Wang SW. Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy. Int J Mol Sci 2013; 14: 1370-1382 [PMID: 23344047]
149. Chu YL, Ho CT, Chung JG, Rajasekaran R, Sheen LY. Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells. J Agric Food Chem 2012; 60: 8363-8371 [PMID: 22860996 DOI: 10.1021/jf301298y]
150. Gong K, Zhang Z, Chen Y, Shu HB, Li W. Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma. Eur J Pharmacol 2014; 738: 142-152 [PMID: 24886888 DOI: 10.1016/j.ejphar.2014.05.034]
151. Muehlich S, Gudermann T. Pro-senescence therapy for hepatocellular carcinoma. Aging (Albany NY) 2013; 5: 639-640 [PMID: 24057649]
152. Hu B, An HM, Shen KP, Xu L, DU Q, Deng S, Wu Y. Liver Yin deficiency tonifying herbal extract induces apoptosis and cell senescence in Bel-7402 human hepatocarcinoma cells. Exp Ther Med 2012; 3: 80-86 [PMID: 22969849 DOI: 10.3892/etm.2011.364]
153. Chang UM, Li CH, Lin LI, Huang CP, Kan LS, Lin SB. Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci 2006; 79: 1129-1139 [PMID: 16635496 DOI: 10.1016/j.lfs.2006.03.027]
154. Hu B, Du Q, Deng S, An HM, Pan CF, Shen KP, Xu L, Wei MM, Wang SS. Ligustrum lucidum Ait. fruit extract induces apoptosis and cell senescence in human hepatocellular carcinoma cells through upregulation of p21. Oncol Rep 2014; 32: 1037-1042 [PMID: 25017491 DOI: 10.3892/or.2014.3312]
155. Cao L, Han L, Zhang Z, Li J, Qu Z, Du J, Liang X, Liu Y, Liu H, Shi Y, Liu S, Gao L, Sun W. Involvement of anoikis-resistance in the metastasis of hepatoma cells. Exp Cell Res 2009; 315: 1148-1156 [PMID: 19073174 DOI: 10.1016/j.yexcr.2008.11.010]
156. Hu B, An HM, Shen KP, Xu L, Du Q, Deng S, Wu Y. Modified Yi Guan Jian, a Chinese herbal formula, induces anoikis in Bel-7402 human hepatocarcinoma cells in vitro. Oncol Rep 2011; 26: 1465-1470 [PMID: 21822542 DOI: 10.3892/or.2011.1414]
157. Hu B, An HM, Shen KP, Song HY, Deng S. Polygonum cuspidatum Extract Induces Anoikis in Hepatocarcinoma Cells Associated with Generation of Reactive Oxygen Species and Downregulation of Focal Adhesion Kinase. Evid Based Complement Alternat Med 2012; 2012: 607675 [PMID: 23008742 DOI: 10.1155/2012/607675]
158. Cheng HL, Su SJ, Huang LW, Hsieh BS, Hu YC, Hung TC, Chang KL. Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation. Mol Cancer 2010; 9: 126 [PMID: 20507639 DOI: 10.1186/1476-4598-9-126]
159. Wang N, Feng Y, Lau EP, Tsang C, Ching Y, Man K, Tong Y, Nagamatsu T, Su W, Tsao S. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr Cancer Ther 2010; 9: 354-364 [PMID: 21106616 DOI: 10.1177/1534735410379121]
160. Xiao XL, Wang XY, Pu X, Guo QX, Long HA. Effect of Baicalein on the in Vitro migration and invasion of human hepatocellular carcinoma cell line SMMC-7721. Zhongguo Zhongliu Linchuang 2012; 39: 305-309
161. Yu HB, Zhang HF, Li DY, Zhang X, Xue HZ, Zhao SH. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res 2011; 13: 242-250 [PMID: 21409686 DOI: 10.1080/10286020.2010.551641]
162. Wei PL, Tu CC, Chen CH, Ho YS, Wu CT, Su HY, Chen WY, Liu JJ, Chang YJ. Shikonin suppresses the migratory ability of hepatocellular carcinoma cells. J Agric Food Chem 2013; 61: 8191-8197 [PMID: 23899086 DOI: 10.1021/jf4009586]
163. Chen D, Yao WJ, Zhang XL, Han XQ, Qu XY, Ka WB, Sun DG, Wu XZ, Wen ZY. Effects of Gekko sulfated polysaccharide-protein complex on human hepatoma SMMC-7721 cells: inhibition of proliferation and migration. J Ethnopharmacol 2010; 127: 702-708 [PMID: 19969061 DOI: 10.1016/j.jep.2009.12.003]
164. Lou L, Ye W, Chen Y, Wu S, Jin L, He J, Tao X, Zhu J, Chen X, Deng A, Wang J. Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine 2012; 19: 603-608 [PMID: 22349030 DOI: 10.1016/j.phymed.2012.01.003]
165. Cao XC, Wang H, Zhang HM, Liu YW, Lu ZX. The effects of plumbagin on proliferation and metastasis in human liver cancer SK-hep-1 cells. Zhongguo Aizheng Zazhi 2013; 23: 721-727
166. Yuxian X, Feng T, Ren L, Zhengcai L. Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo. Tumori 2009; 95: 789-795 [PMID: 20210245 DOI: 10.1700/467.5521]
167. Jia QA, Wang ZM, Ren ZG, Bu Y, Xie XY, Wang YH, Zhang L, Zhang QB, Xue TC, Deng LF, Tang ZY. Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells. BMC Complement Altern Med 2013; 13: 89 [PMID: 23622143 DOI: 10.1186/1472-6882-13-89]
168. Cheng Y, He SQ, Zhu Y, Fan Q, Yang S, Chen R. [Blejiajian pill inhibited the proliferation, adhesion, and invasion of hepatoma carcinoma cells: an experimental research]. Zhongguo Zhongxiyi Jiehe Zazhi 2013; 33: 664-667 [PMID: 23905388]
169. Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell. J Gastroenterol Hepatol 2010; 25: 420-426 [PMID: 19793165 DOI: 10.1111/j.1440-1746.2009.05981.x]
170. Ding XM, Cheng ZR. Study on inhibitory effect of Shehuang Xiaoliu Fang on invasive and adhesive ability of liver cancer cells. Zhongxiyi Jiehe Ganbing Zazhi 2006; 16: 96-98
171. He YL, Ying Y, Xu YL, Su JF, Luo H, Wang HF. [Effects of Lycium barbarum polysaccharide on tumor microenvironment T-lymphocyte subsets and dendritic cells in H22-bearing mice]. Zhongxiyi Jiehe Xuebao 2005; 3: 374-377 [PMID: 16159572 DOI: 10.3736/jcim20050511]
172. Chiu JH, Ju CH, Wu LH, Lui WY, Wu CW, Shiao MS, Hong CY. Cordyceps sinensis increases the expression of major histocompatibility complex class II antigens on human hepatoma cell line HA22T/VGH cells. Am J Chin Med 1998; 26: 159-170 [PMID: 9799968 DOI: 10.1142/S0192415X9800021X]
173. Dai ZJ, Liu XX, Tang W, Xue Q, Wang XJ, Ji ZZ, Kang HF, Diao Y. [Antitumor and immune-modulating effects of Scutellaria barbata extract in mice bearing hepatocarcinoma H22 cells-derived tumor]. Nanfang Yike Daxue Xuebao 2008; 28: 1835-1837 [PMID: 18971184]
174. Chen YT, Lin MA, Cheng DQ, Shi ZJ, Zhu JL, Wu J. [Effect of proteins extracted from mycelia of Omphalia lapidescens on inhibiting H, liver cancer in mice and regulating immune function]. Zhongyaocai 2009; 32: 1870-1874 [PMID: 20432906]
175. Li J, Xie M, Gan Y. [Effect of Xiaochaihu decoction and different herbal formulation of component on inhibiting H22 liver cancer in mice and enhancing immune function]. Zhongguo Zhongyao Zazhi 2008; 33: 1039-1044 [PMID: 18652353]
176. Zhou AG, Zhang Y, Kong DY, Wang Y, Zhang HZ, Wang SJ, Kui G, Hong S, Ge HL, Ren QH, Mao XM, Dong JR. [Tumor inhibiting and immunoloregulation effects of Mylabris Mixture on H22 cancer-bearing mice]. Zhongxiyi Jiehe Xuebao 2006; 4: 504-508 [PMID: 16965746 DOI: 10.3736/jcim20060513]
177. Cao ZY, Chen XZ, Liao LM, Peng J, Hu HX, Liu ZZ, Du J. Fuzheng Yiliu Granule inhibits the growth of hepatocellular cancer by regulating immune function and inducing apoptosis in vivo and in vitro. Chin J Integr Med 2011; 17: 691-697 [PMID: 21910071 DOI: 10.1007/s11655-011-0847-3]
178. Li XJ, Mao YX, Zhang HL, Wang JX, Liu FY. [Study on effects of anticancer and immunoregulation of Fuganchun 6 on hepatoma of mouse]. Zhongguo Zhongyao Zazhi 2006; 31: 1622-1625 [PMID: 17165590]
179. Chen JR, Li EQ, Dai CQ, Yu B, Wu XL, Huang CR, Chen XY. The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC). Curr Drug Deliv 2012; 9: 414-420 [PMID: 22640039 DOI: 10.2174/156720112801323107]
180. Chen D, Zhang X, Du Y, Jia B, Ka W, Sun D, Yao W, Wen Z. Effects of Gekko sulfated polysaccharide-protein complex on the defective biorheological characters of dendritic cells under tumor microenvironment. Cell Biochem Biophys 2012; 62: 193-201 [PMID: 21913004 DOI: 10.1007/s12013-011-9282-5]
181. He X, Li X, Liu B, Xu L, Zhao H, Lu A. Down-regulation of Treg cells and up-regulation of TH1/TH2 cytokine ratio were induced by polysaccharide from Radix Glycyrrhizae in H22 hepatocarcinoma bearing mice. Molecules 2011; 16: 8343-8352 [PMID: 21963624 DOI: 10.3390/molecules16108343]
182. Deng S, Hu B, An HM, Du Q, Xu L, Shen KP, Shi XF, Wei MM, Wu Y. Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5--Fluorouracil in CT26 colon carcinoma. BMC Complement Altern Med 2013; 13: 128 [PMID: 23758730 DOI: 10.1186/1472-6882-13-128]
183. Bishayee A, Darvesh AS. Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy. Curr Cancer Drug Targets 2012; 12: 1095-1118 [PMID: 22873221 DOI: 10.2174/15680096112091095]
184. Song P, Wang XM, Xie S. [Experimental study on mechanisms of lyophilized powder of fresh gekko Chinenis in inhibiting H22 hepatocarcinoma angiogenesis]. Zhongguo Zhongxiyi Jiehe Zazhi 2006; 26: 58-62 [PMID: 16466175]
185. Zhang SX, Zhu C, Ba Y, Chen D, Zhou XL, Cao R, Wang LP, Ren Y, Wu XZ. Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factor. J Biol Chem 2012; 287: 13206-13215 [PMID: 22371501 DOI: 10.1074/jbc.M111.321521]
186. Feng GS, Li X, Zheng CS, Zhou CK, Liu X, Wu HP. [Mechanism of inhibition of tumor angiogenesis by Bletilla colloid: an experimental study]. Zhonghua Yixue Zazhi 2003; 83: 412-416 [PMID: 12820920]
187. Ren J, Zheng C, Feng G, Liang H, Xia X, Fang J, Duan X, Zhao H. Inhibitory effect of extract of fungi of Huaier on hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 2009; 29: 198-201 [PMID: 19399404 DOI: 10.1007/s11596-009-0212-3]
188. Liu SJ, Shen WL, Liu XL, Wen J, Cui YZ. Anti-angiogenesis effects of Fu-Zheng-Kang-Ai-Tang in the treatment of hepatocarcinoma. Shijie Huaren Xiaohua Zazhi 2005; 13: 908-910
189. Cui J, Nan KJ, Tian T, Guo YH, Zhao N, Wang L. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture. World J Gastroenterol 2007; 13: 5432-5439 [PMID: 17907285 DOI: 10.3748/wjg.v13.i41.5432]
190. Chen T, Fu YL, Gong ZP, Deng LR, Hu YQ. Studies on the anti-angiogenic mechanism of the formula of Chinese medicine active ingredients combined with small dose cisplatin in mice of hepatocellular carcinoma. Zhongguo Shiyan Fangji Xue Zazhi 2010; 16: 157-160
191. Wang S, Xu X, Zhang W, Li A, Dong W. [Effects of Erbie San on Walker-256 liver cancer and adjustment to unbalance of VEGF/endostatin in rats]. Zhongguo Zhongyao Zazhi 2009; 34: 89-91 [PMID: 19382459]
192. Dai Z, Liu X, Ji Z, Liu L, Kang H, Wang X, Diao Y. The effect-enhancing and toxicity-reducing action of the extract of herba Scutellariae barbatae for chemotherapy in hepatoma H22 tumorbearing mice. J Tradit Chin Med 2008; 28: 205-210 [PMID: 19004205 DOI: 10.1016/S0254-6272(08)60048-5]
193. Wang DH, Weng XC. [Antitumor activity of extracts of Ganoderma lucidum and their protective effects on damaged HL-7702 cells induced by radiotherapy and chemotherapy]. Zhongguo Zhongyao Zazhi 2006; 31: 1618-1622 [PMID: 17165589]
194. Sun Y, Guan J, Wang Q. The influence of Cordyceps sinensis on the immunologic function of the rats with liver cancer (H22) after chemotherapy. Zhongguo Jiceng Yiyao 2002; 9: 127-128
195. You M, Luo M, Liao W, Hu S, Xu W, Jing L. [Chaiqiyigan granula enhances Taxol-induced growth inhibition of hepatocellular carcinoma xenografts in nude mice: an in vivo fluorescence imaging study]. Nanfang Yike Daxue Xuebao 2012; 32: 1042-1045 [PMID: 22820595]
196. Chen T, Li D, Fu YL, Hu W. Screening of QHF formula for effective ingredients from Chinese herbs and its anti-hepatic cell cancer effect in combination with chemotherapy. Chin Med J (Engl) 2008; 121: 363-368 [PMID: 18304471]
197. Chen Z, Wang P, Huang WX, Liu LM. [Experimental study on effects of shengmai injection: enhancing 5-FU anti-tumor efficacy and reducing its toxicity]. Zhongxiyi Jiehe Xuebao 2005; 3: 476-479 [PMID: 16282061 DOI: 10.3736/jcim20050615]
198. Yau T, Chan P, Epstein R, Poon RT. Evolution of systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol 2008; 14: 6437-6441 [PMID: 19030192 DOI: 10.3748/wjg.14.6437]
199. Tian QE, Li HD, Yan M, Cai HL, Tan QY, Zhang WY. Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice. World J Gastroenterol 2012; 18: 7079-7086 [PMID: 23323011 DOI: 10.3748/wjg.v18.i47.7079]
200. Huang C, Xu D, Xia Q, Wang P, Rong C, Su Y. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II. J Pharm Pharmacol 2012; 64: 1741-1750 [PMID: 23146037 DOI: 10.1111/j.2042-7158.2012.01549. x]
201. Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, Tang H, Li QQ. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 2010; 37: 111-123 [PMID: 20514403 DOI: 10.3892/ijo_00000659]
202. Wang XB, Wang SS, Zhang QF, Liu M, Li HL, Liu Y, Wang JN, Zheng F, Guo LY, Xiang JZ. Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells. Oncol Rep 2010; 23: 211-215 [PMID: 19956884 DOI: 10.3892/or_00000625]
203. Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB, Ko BC. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Clin Cancer Res 2005; 11: 6002-6011 [PMID: 16115945 DOI: 10.1158/1078-0432.CCR-05-0209]
204. Ong RC, Lei J, Lee RK, Cheung JY, Fung KP, Lin C, Ho HP, Yu B, Li M, Kong SK. Polyphyllin D induces mitochondrial fragmentation and acts directly on the mitochondria to induce apoptosis in drug-resistant HepG2 cells. Cancer Lett 2008; 261: 158-164 [PMID: 18082940 DOI: 10.1016/j.canlet.2007.11.005]
205. Chaudhary H, Jena PK, Seshadri S. Evaluation of hydro-alcoholic extract of Eclipta alba for its multidrug resistance reversal potential: an in vitro study. Nutr Cancer 2013; 65: 775-780 [PMID: 23859045 DOI: 10.1080/01635581.2013.789116]